Table 2. Percentage of patients with recurrence within 5 years from diagnosis of cervical cancer stratified by quartiles of CD66b+ neutrophil count and CD163+ macrophage cell density.
Quartiles | Cells per mm 2 or area fraction | % Of patients recurred |
---|---|---|
Neutrophils tumour nests
| ||
I | 0–8.5 | 28 |
II | 8.6–23.1 | 20 |
III | 23.2–68.9 | 31 |
IV |
69.0–939.3 |
44 |
Neutrophils peritumoural
| ||
I | 2–18.1 | 24 |
II | 18.2–53.1 | 16 |
III | 53.2–125.2 | 35 |
IV |
125.3–677.1 |
48 |
Neutrophils stroma
| ||
I | 0–8.5 | 16 |
II | 8.6–28.3 | 24 |
III | 28.4–66.8 | 27 |
IV |
66.7–780 |
56 |
Macrophages tumour nests
| ||
I | 0–0.021 | 21 |
II | 0.022–0.18 | 29 |
III | 0.22–0.99 | 23 |
IV |
1.0–12 |
52 |
Macrophages peritumoural
| ||
I | 0–0.46 | 20 |
II | 0.47–1.27 | 24 |
III | 1.28–3.0 | 39 |
IV |
3.1–16.6 |
40 |
Macrophages stroma
| ||
I | 0–0.26 | 20 |
II | 0.27–0.73 | 32 |
III | 0.74–2.1 | 23 |
IV | 2.2–9.4 | 48 |